These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35506275)

  • 41. Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations.
    Kaneda-Nakashima K; Shirakami Y; Kadonaga Y; Watabe T
    PET Clin; 2023 Jul; 18(3):397-408. PubMed ID: 36997365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
    Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.
    Kelly T; Huang Y; Simms AE; Mazur A
    Int Rev Cell Mol Biol; 2012; 297():83-116. PubMed ID: 22608558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment.
    Kim MG; Shon Y; Kim J; Oh YK
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions.
    Ora M; Soni N; Nazar AH; Dixit M; Singh R; Puri S; Graham MM; Gambhir S
    J Nucl Med; 2023 Jul; 64(7):1001-1008. PubMed ID: 37268422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review.
    Zhao L; Chen J; Pang Y; Fu K; Shang Q; Wu H; Sun L; Lin Q; Chen H
    Theranostics; 2022; 12(4):1557-1569. PubMed ID: 35198057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment.
    Lin Y; Li B; Yang X; Cai Q; Liu W; Tian M; Luo H; Yin W; Song Y; Shi Y; He R
    Neoplasia; 2019 Dec; 21(12):1133-1142. PubMed ID: 31759251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.
    Tchou J; Zhang PJ; Bi Y; Satija C; Marjumdar R; Stephen TL; Lo A; Chen H; Mies C; June CH; Conejo-Garcia J; Puré E
    Hum Pathol; 2013 Nov; 44(11):2549-57. PubMed ID: 24074532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review).
    Zi F; He J; He D; Li Y; Yang L; Cai Z
    Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
    Hu M; Qian C; Hu Z; Fei B; Zhou H
    OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
    LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR
    Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the Peptidase "Fibroblast Activation Protein" on Decidual Stromal Cells Facilitating Tissue Remodeling.
    Segerer SE; Bartmann C; Schwab M; Kämmerer U
    Gynecol Obstet Invest; 2020; 85(5):428-436. PubMed ID: 33171480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules.
    Slania SL; Das D; Lisok A; Du Y; Jiang Z; Mease RC; Rowe SP; Nimmagadda S; Yang X; Pomper MG
    J Med Chem; 2021 Apr; 64(7):4059-4070. PubMed ID: 33730493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Evaluation of
    Bendre S; Zhang Z; Colpo N; Zeisler J; Wong AAWL; Bénard F; Lin KS
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibroblast activation protein-based theranostics in pancreatic cancer.
    Cheng CS; Yang PW; Sun Y; Song SL; Chen Z
    Front Oncol; 2022; 12():969731. PubMed ID: 36263225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment.
    Lückerath K; Trajkovic-Arsic M; Mona CE
    PET Clin; 2023 Jul; 18(3):409-418. PubMed ID: 36990945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.